Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06697093 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

Study acronym: CaS-POL
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 2, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Jun 1, 2025 to Apr 1, 2026
    • Start date: Dec 1, 2024 to Apr 1, 2025
    • Study sites: 1 to 2
    • Study completion date: Jul 1, 2025 to Dec 31, 2026
    • Collaborators revised (2)
  2. Collaborators revised (2)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support. It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.
Trial Details
NCT Number NCT06697093
Lead Sponsor Wroclaw Medical University
Collaborators: Polish Cardiac Society, Johnson & Johnson
Conditions
(from sponsor)		 Cardiogenic Shock
Related terms Myocardial Infarction, Shock, Cardiogenic
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov